A genetic variant in the promoter region of mir-106b-25 cluster and risk of hbv infection and hepatocellular carcinoma

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Liu, Yao ^a   Zhang, Yixin ^b   Wen, Juan ^a   Liu, Li ^b,c   Zhai, Xiangjun ^d   Liu, Jibin ^b   Pan, Shandong ^a   Chen, Jianguo ^e   Shen, Hongbing ^a   Hu, Zhibin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG TUMOR HOSPITAL   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Qidong Liver Cancer Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; MICRORNA; MIRN106 MICRORNA, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEPATITIS B; HUMAN; HUMAN TISSUE; INFECTION RISK; INTRON; LIVER CELL CARCINOMA; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; LIVER TUMOR; MULTIGENE FAMILY; RISK; VIROLOGY;

HEPATITIS B VIRUS;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMANS; INTRONS; LIVER NEOPLASMS; MICRORNAS; MULTIGENE FAMILY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84863245920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032230     Document Type: Article

References (30)

1. He J, Gu D, Wu X, Reynolds K, Duan X, et al. (2005) Major causes of death among men and women in China. N Engl J Med 353: 1124-1134.
2. Zhu ZZ, Cong WM, (2003) Roles of hepatitis B virus and hepatitis C virus in hepato-carcinogenesis. Zhonghua Gan Zang Bing Za Zhi 11: 574-576.
3. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, et al. (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85: 498-502.
4. Chuang SC, La Vecchia C, Boffetta P, (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286: 9-14.
5. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
6. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
7. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, et al. (2011) MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology 140: 1618-1628.
8. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
9. Li J, Wang Y, Yu W, Chen J, Luo J, (2011) Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406: 70-73.
10. Gao P, Wong CC, Tung EK, Lee JM, Wong CM, et al. (2011) Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 54: 1177-1184.
11. Li Y, Tan W, Neo TW, Aung MO, Wasser S, et al. (2009) Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 100: 1234-1242.
12. Spierings DC, McGoldrick D, Hamilton-Easton AM, Neale G, Murchison EP, et al. (2011) Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 117: 5340-5349.
13. Zeiner GM, Norman KL, Thomson JM, Hammond SM, Boothroyd JC, (2010) Toxoplasma gondii infection specifically increases the levels of key host microRNAs. PLoS One 5: e8742.
14. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
15. Hu L, Zhai X, Liu J, Chu M, Pan S, et al. (2011) Genetic variants in HLA-DP/DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology [Epub ahead of print].
16. Fang L, Deng Z, Shatseva T, Yang J, Peng C, et al. (2011) MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 30: 806-821.
17. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
18. Kan T, Meltzer SJ, (2009) MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9: 727-732.
19. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657.
20. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, et al. (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170.
21. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
22. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
23. De Santis G, Ferracin M, Biondani A, Caniatti L, Rosaria Tola M, et al. (2010) Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226: 165-171.
24. Hu S, Dong TS, Dalal SR, Wu F, Bissonnette M, et al. (2011) The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 6: e16221.
25. Kim YK, Yu J, Han TS, Park SY, Namkoong B, et al. (2009) Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681.
26. Petrocca F, Vecchione A, Croce CM, (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194.
27. Kan T, Sato F, Ito T, Matsumura N, David S, et al. (2009) The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
28. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, et al. (2010) Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
29. Ohe K, Lalli E, Sassone-Corsi P, (2002) A direct role of SRY and SOX proteins in pre-mRNA splicing. Proc Natl Acad Sci U S A 99: 1146-1151.
30. Phillips NB, Nikolskaya T, Jancso-Radek A, Ittah V, Jiang F, et al. (2004) Sry-directed sex reversal in transgenic mice is robust with respect to enhanced DNA bending: comparison of human and murine HMG boxes. Biochemistry 43: 7066-7081.